Thai Ba Trieu

Array ( [id] => 6119225 [patent_doc_number] => 20110076700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'ANTI-CRP ANTIBODY AND UTILIZATION OF THE SAME' [patent_app_type] => utility [patent_app_number] => 12/920192 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5683 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076700.pdf [firstpage_image] =>[orig_patent_app_number] => 12920192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574968 [patent_doc_number] => 20090142329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4' [patent_app_type] => utility [patent_app_number] => 12/197977 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142329.pdf [firstpage_image] =>[orig_patent_app_number] => 12197977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418037 [patent_doc_number] => 20100167348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'PEPTIDE CAPABLE OF BINDING TO IMMUNOGLOBULIN' [patent_app_type] => utility [patent_app_number] => 12/733288 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10457 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167348.pdf [firstpage_image] =>[orig_patent_app_number] => 12733288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527260 [patent_doc_number] => 08043852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Monoclonal antibody specific to dentin-derived heparan sulfate' [patent_app_type] => utility [patent_app_number] => 12/222889 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7380 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043852.pdf [firstpage_image] =>[orig_patent_app_number] => 12222889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416333 [patent_doc_number] => 20090042220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Method for monitoring collagen type II degradation in cartilage' [patent_app_type] => utility [patent_app_number] => 12/222352 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6078 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042220.pdf [firstpage_image] =>[orig_patent_app_number] => 12222352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792187 [patent_doc_number] => 20080293161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Detection of Carbohydrate Biomarkers' [patent_app_type] => utility [patent_app_number] => 12/187159 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8059 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293161.pdf [firstpage_image] =>[orig_patent_app_number] => 12187159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928926 [patent_doc_number] => 20110038885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'CHEMOKINE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/670720 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24484 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038885.pdf [firstpage_image] =>[orig_patent_app_number] => 12670720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282686 [patent_doc_number] => 08216788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Detection of infectious prion protein by seeded conversion of recombinant prion protein' [patent_app_type] => utility [patent_app_number] => 12/177012 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 43 [patent_no_of_words] => 32849 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12177012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536315 [patent_doc_number] => 20100015645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'IL-8 AS BIOMARKER FOR THE DETECTION OF UROLITHIASIS' [patent_app_type] => utility [patent_app_number] => 12/175674 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5446 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015645.pdf [firstpage_image] =>[orig_patent_app_number] => 12175674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265015 [patent_doc_number] => 20100297679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'IDENTIFICATION AND QUANTIFICATION OF BIOMARKERS FOR EVALUATING THE RISK OF PRETERM BIRTH' [patent_app_type] => utility [patent_app_number] => 12/669343 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12776 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297679.pdf [firstpage_image] =>[orig_patent_app_number] => 12669343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777675 [patent_doc_number] => 08852879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Materials and methods for the detection of nitrated fibrinogen' [patent_app_type] => utility [patent_app_number] => 12/168739 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 18499 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12168739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640673 [patent_doc_number] => 20100227415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHOD AND MEANS FOR PREDICTION OF SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY' [patent_app_type] => utility [patent_app_number] => 12/670370 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4511 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227415.pdf [firstpage_image] =>[orig_patent_app_number] => 12670370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4506151 [patent_doc_number] => 07915001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Detection of specific nitrated markers' [patent_app_type] => utility [patent_app_number] => 12/216063 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7911 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915001.pdf [firstpage_image] =>[orig_patent_app_number] => 12216063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681685 [patent_doc_number] => 20080247911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Measurement of Concentrations and Binding Energetics' [patent_app_type] => utility [patent_app_number] => 12/140230 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5705 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247911.pdf [firstpage_image] =>[orig_patent_app_number] => 12140230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349318 [patent_doc_number] => 20090004679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'METHOD FOR DETERMINING PLASMINOGEN ACTIVATOR INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/138248 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6185 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004679.pdf [firstpage_image] =>[orig_patent_app_number] => 12138248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538229 [patent_doc_number] => 08313950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Hepcidins as biomarkers for impending lupus nephritis flare' [patent_app_type] => utility [patent_app_number] => 12/600890 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 13978 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422411 [patent_doc_number] => 20090148866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase' [patent_app_type] => utility [patent_app_number] => 12/122244 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22551 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148866.pdf [firstpage_image] =>[orig_patent_app_number] => 12122244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007518 [patent_doc_number] => 20110059549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/118396 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 32581 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059549.pdf [firstpage_image] =>[orig_patent_app_number] => 12118396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564084 [patent_doc_number] => 20090136937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHODS AND SYSTEMS FOR MONITORING PRODUCTION OF A TARGET PROTEIN IN A NANOLIPOPROTEIN PARTICLE' [patent_app_type] => utility [patent_app_number] => 12/118530 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24412 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136937.pdf [firstpage_image] =>[orig_patent_app_number] => 12118530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839891 [patent_doc_number] => 20080280377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'HUMAN B-TYPE NATRIURETIC PEPTIDE ASSAY HAVING REDUCED CROSS-REACTIVITY WITH OTHER PEPTIDE FORMS' [patent_app_type] => utility [patent_app_number] => 12/117055 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21147 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280377.pdf [firstpage_image] =>[orig_patent_app_number] => 12117055 [rel_patent_id] =>[rel_patent_doc_number] =>)